Amy D. Rock

ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial

John Wrangle, Vamsidhar Velcheti, Manish R. Patel et al. · The Lancet Oncology · 2018 · 426 citations

Medicine, Immunology, Oncology +12

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott et al. · Blood · 2018 · 407 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9

Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors

Kim Margolin, Chihiro Morishima, Vamsidhar Velcheti et al. · Clinical Cancer Research · 2018 · 206 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain

Stephen Southworth, Jeannine Peters, Amy D. Rock et al. · Clinical Therapeutics · 2009 · 138 citations

Medicine, Anesthesiology, Perioperative Medicine +13

A Multi-Center, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients

Neil Singla, Amy D. Rock, Leo Pavliv · Pain Medicine · 2010 · 95 citations · Full text

Medicine, Orthopedic Surgery, Surgery +17